Phibro Animal Health
PAHC
33.29
-0.79
-2.32%
Phibro Animal Health
US · PAHC
#2966 by market cap
Listed 1970
33.29
-0.79
-2.32%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Earnings Flash (PAHC) Phibro Animal Health Corporation Posts Q1 Adjusted EPS $0.79 per Share, Vs. FactSet Est of $0.78MT Newswires · 2026/11/5
-
Rating change
Morgan Stanley Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Raises Target Price to $45Market Newswire · 2025/11/8
-
Earnings Flash (PAHC) Phibro Animal Health Corporation Reports Q1 Revenue $386.8M, Vs. FactSet Est of $382.4MMT Newswires · 2026/11/5
-
Rating change
J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy RatingMarket Newswire · 2026/6/12
-
Rating change
J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Announces Target Price $58Market Newswire · 2026/8/25
-
Rating change
BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $32Market Newswire · 2026/1/30
-
Rating change
BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Maintains Target Price $32Market Newswire · 2026/2/5
-
Rating change
J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Cuts Target Price to $55Market Newswire · 2026/9/2
-
Rating change
Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Maintains Target Price $62Market Newswire · 2026/4/16
-
Rating change
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)TipRanks · 2026/7/28
-
Phibro Animal Health (PAHC.US) will release its financial report after hours on November 4.Market Newswire · 2026/10/30
-
Rating change
J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Raises Target Price to $58Market Newswire · 2026/2/9
-
Rating change
J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Raises Target Price to $50Market Newswire · 2025/11/7
-
J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Maintains Target Price $55Market Newswire · 2026/10/16
-
Rating change
BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $38Market Newswire · 2026/2/6
-
Rating change
Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Maintains Target Price $44Market Newswire · 2026/5/14
-
Form 144 | Phibro Animal Health(PAHC.US) 10% Stockholder Proposes to Sell 12.36 Million in Common StocksMarket Newswire · 2026/9/17
-
Rating change
Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Cuts Target Price to $44Market Newswire · 2026/5/14
-
Rating change
Citi Initiates Phibro Animal Health(PAHC.US) With Hold Rating, Announces Target Price $62Market Newswire · 2026/4/15
-
Rating change
BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell RatingMarket Newswire · 2026/7/28
-
Rating change
BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Maintains Target Price $27Market Newswire · 2025/8/29
-
Rating change
J.P. Morgan Reaffirms Their Buy Rating on Phibro Animal Health (PAHC)TipRanks · 2025/9/1
-
Rating change
BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $27Market Newswire · 2025/8/29
-
Earnings Flash (PAHC) Phibro Animal Health Posts Fiscal Q4 Revenue $396.7M, Vs. FactSet Est of $381.2MMT Newswires · 2026/8/27
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Phibro Animal Health discussion 0 comments